6830183|t|No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
6830183|a|Eight patients with clinically diagnosed mild to severe Alzheimer disease were treated during two six-week periods by a double-blind, single-crossover protocol with placebo or a combination of 18 gm of lecithin and 3 to 10 mg of oral physostigmine daily. No improvement in behavior, recent memory, or other neuropsychological functions occurred.
6830183	37	50	physostigmine	Chemical	MESH:D010830
6830183	55	63	lecithin	Chemical	MESH:D054709
6830183	67	84	Alzheimer disease	Disease	MESH:D000544
6830183	92	100	patients	Species	9606
6830183	142	159	Alzheimer disease	Disease	MESH:D000544
6830183	288	296	lecithin	Chemical	MESH:D054709
6830183	320	333	physostigmine	Chemical	MESH:D010830
6830183	Comparison	MESH:D010830	MESH:D054709

